Keith Parent, CEO of Court Square Group, discusses the complexities of the life science industry and introduces Chris Matheus from the Global Life Science Alliance (GLSA). Chris, with 30 years in clinical research, co-founded GLSA to connect smaller companies with business development opportunities and experts. The conversation emphasizes the importance of collaboration and networking, highlighting GLSA's role in facilitating connections for regulatory consulting, pre-clinical, and clinical trial management, and innovative solutions such as AI. Chris and Keith also talk about "Friends of Chris Matheus" (FOCM), a networking club he founded to foster industry connections. The conversation underscores the need for efficient, cost-effective solutions to support drug development and innovation.